Mallinckrodt has been granted a patent for a delivery system that provides clinical decision support for delivering therapeutic gas, such as nitric oxide, to patients. The system includes a control module, sample block, and display to monitor and adjust gas mixture delivery, including nebulizer use. GlobalData’s report on Mallinckrodt gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Mallinckrodt, was a key innovation area identified from patents. Mallinckrodt‘s grant share as of January 2024 was 55%. Grant share is based on the ratio of number of grants to total number of patents.
Clinical decision support system for delivering therapeutic gas to patients
A recently granted patent (Publication Number: US11833299B2) discloses a novel therapeutic gas delivery system that includes a control module, a sample block, and a display. The system is designed to control the flow of therapeutic gas, such as nitric oxide, mixed with a breathing gas for delivery to a patient through a nebulizer device. The control module stores information related to the nebulizer mode, start information, and duration of operation. It can pause the evaluation of the gas mixture when the nebulizer is in use based on user input, resume evaluation after a set duration, and display the calculated dose of nitric oxide. The system aims to optimize the delivery of therapeutic gases to patients efficiently and accurately.
Furthermore, the patent describes a feature where the system can test the gas mixture for various concentrations when not in nebulizer mode, but pause testing during nebulizer operation based on user-defined duration. The control module can provide alerts for dosage thresholds, enter nebulizer mode upon user input, and display calculated delivery concentrations. The system also includes a sensor to measure flow rates and a sample block to analyze gas concentrations. With user-friendly features like touch screen input and customizable settings, this therapeutic gas delivery system offers a comprehensive solution for precise and effective delivery of therapeutic gases to patients. The patent highlights the innovative approach to optimizing gas mixture delivery and monitoring in medical settings, potentially improving patient outcomes and treatment efficacy.
To know more about GlobalData’s detailed insights on Mallinckrodt, buy the report here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
